Patent Application Titled "Methods Of Preventing A Venous Thromboembolic Event" Published Online (USPTO 20240423980).

A patent application titled "Methods Of Preventing A Venous Thromboembolic Event" was published online by inventors from Bossier City and Shreveport, Louisiana. The application focuses on preventing, treating, or alleviating symptoms of venous thromboembolic events by administering an endothelin receptor inhibitor, particularly an integrin alpha9 (ITGA9) inhibitor. The method targets conditions such as deep vein thrombosis, pulmonary embolism, and cancer-associated thrombosis, with a focus on patients undergoing anti-cancer therapeutic regimens. The application also suggests administering a thromboprophylaxis regimen with antithrombotic agents like warfarin, heparin, dabigatran, rivaroxaban, or apixaban. [Extracted from the article]